GENELUX Corp — Investor Relations & Filings
Genelux Corporation is a clinical-stage biopharmaceutical company developing next-generation oncolytic viral immunotherapies for patients with aggressive and difficult-to-treat solid tumors. The company's technology is based on a proprietary discovery platform, CHOICE™, which utilizes an engineered vaccinia virus (VACV) as its backbone. This approach creates "off-the-shelf" therapeutics designed to selectively replicate within and kill cancer cells, stimulating a robust, patient-specific anti-tumor immune response. The lead product candidate, Olvi-Vec, is a modified vaccinia virus administered systemically. It is currently being evaluated in a registrational Phase 3 clinical trial for the treatment of platinum-resistant/refractory ovarian cancer. The company is also preparing for a Phase 2 trial in recurrent non-small cell lung cancer.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - GENELUX Corp (0001231457) (Filer) | 2026-04-29 | English | |
| DEF 14A - GENELUX Corp (0001231457) (Filer) | 2026-04-29 | English | |
| 4 - GENELUX Corp (0001231457) (Issuer) | 2026-03-26 | English | |
| 4 - GENELUX Corp (0001231457) (Issuer) | 2026-03-26 | English | |
| 4 - GENELUX Corp (0001231457) (Issuer) | 2026-03-26 | English | |
| 4 - GENELUX Corp (0001231457) (Issuer) | 2026-03-26 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38557262 | ARS - GENELUX Corp (0001231457) (Filer) | 2026-04-29 | English | ||
| 38550613 | DEF 14A - GENELUX Corp (0001231457) (Filer) | 2026-04-29 | English | ||
| 33052416 | 4 - GENELUX Corp (0001231457) (Issuer) | 2026-03-26 | English | ||
| 33052413 | 4 - GENELUX Corp (0001231457) (Issuer) | 2026-03-26 | English | ||
| 33052411 | 4 - GENELUX Corp (0001231457) (Issuer) | 2026-03-26 | English | ||
| 33052412 | 4 - GENELUX Corp (0001231457) (Issuer) | 2026-03-26 | English | ||
| 32989895 | 424B5 - GENELUX Corp (0001231457) (Filer) | 2026-03-19 | English | ||
| 32989872 | S-8 - GENELUX Corp (0001231457) (Filer) | 2026-03-19 | English | ||
| 32989612 | 8-K - GENELUX Corp (0001231457) (Filer) | 2026-03-19 | English | ||
| 32889064 | 4 - GENELUX CORP (0001231457) (Filer) | 2026-03-04 | English | ||
| 28486065 | 8-K Filing | 2026-02-02 | English | ||
| 28485668 | 8-K Filing | 2026-01-08 | English | ||
| 28485632 | 424B5 Filing | 2026-01-08 | English | ||
| 28485717 | 424B5 Filing | 2026-01-07 | English | ||
| 28485646 | 4 Filing | 2026-01-07 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Hemab Therapeutics Holdings, Inc.
Developing novel prophylactic therapeutics for serious, und…
|
COAG | US | Manufacturing |
|
HEMOGENYX PHARMACEUTICALS PLC
Develops cell-based therapies for blood, autoimmune disease…
|
HEMO | GB | Manufacturing |
|
Hempfusion Wellness Inc.
Sells broad-spectrum CBD and probiotic supplements in the h…
|
CBDHF | CA | Manufacturing |
|
HEM Pharma Inc.
Develops microbiome-based healthcare solutions, products, a…
|
376270 | KR | Manufacturing |
|
Hemp Health Spolka Akcyjna
Manages a supply chain for medical marijuana, from cultivat…
|
HMP | PL | Manufacturing |
|
Hempsana Holdings
Specialized manufacturer of cannabis derivatives, extracts,…
|
HMPS | CA | Manufacturing |
|
Henan Lingrui Pharmaceutical Co., Ltd
Produces transdermal drug delivery systems, rubber plasters…
|
600285 | CN | Manufacturing |
|
Henan Taloph Pharmaceutical Stock Co.,Ltd
Researches and produces TCM and chemical drugs for respirat…
|
600222 | CN | Manufacturing |
|
Hengrui Pharma
Global pharmaceutical firm focused on R&D for oncology and …
|
600276 | CN | Manufacturing |
|
Herbs Generation Group Holdings Limited
Develops, markets, and sells health supplements emphasizing…
|
2593 | HK | Manufacturing |
GENELUX Corp via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33857/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33857 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33857 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33857 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33857}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GENELUX Corp (id: 33857)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.